Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Durkadin Demir Eksi has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Elevated Blood Levels of VEGF Exhibiting Positive Correlation with HIF-1α in Obesity: A Single Center Study

    by Nazmiye Uluergüven, Durkadın Demir Ekşi, Erkan Maytalman, Ramazan Güneşaçar

    Aim: The objective of this study was to investigate the relevance of plasma hypoxia-inducible factor-1 alpha (HIF-1α) and vascular endothelial growth factor (VEGF) levels in obesity and their associations with body mass index (BMI), body fat percentage, and waist to-hip ratio. Material and Methods: The study included 45 obese subjects and 28 healthy controls recruited from a private clinic in Manavgat, Antalya. The measurement of BMI, percentage of body fat, and waist-to-hip ratio was conducted in all subjects using a bioelectrical impedance analysis device. The plasma levels of HIF-1α and VEGF were measured using the micro-ELISA method. Results: In the Mann-Whitney U test, HIF-1α levels were similar in obese subjects (median=1.439 ng/L [Interquartile range (IQR)=11.62, min-max=0.904-12.53] and control group (median=1.377 ng/L [1.323, 0.852-2.175], p=0.0821). VEGF levels were found to be significantly higher in obese subjects compared to the controls (medians; 729.8 ng/L [5515, 485.3-6000] vs. 589.5 ng/L, [416.8, 396.4-813.2], respectively, p

  • Open Access

    The Role of Energy Homeostasis-Associated Gene Expression and Serum Adropin Levels in Patients with Familial Mediterranean Fever

    by Durkadin Demir Eksi, Gulay Gulbol Duran, Muhammet Murat Celik, Yunus Emre Eksi, Ramazan Gunesacar

    Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disease primarily affecting populations in the Mediterranean region. The pathogenesis of FMF and the roles of various molecules remain unclear. Adropin, a protein encoded by the Energy Homeostasis-Associated Gene (ENHO), is involved in energy metabolism and inflammation. This study aimed to explore the relationship between ENHO expression, Adropin levels, and FMF, examining their correlations with disease characteristics. This study included 30 patients clinically diagnosed with FMF and 35 healthy controls. The ENHO expression in peripheral blood mononuclear cells was assessed using a qRT-PCR, and the serum Adropin levels were measured via ELISA. The ENHO expression was significantly elevated in the FMF patients compared to the controls (p = 0.0007), while no significant differences were observed in the serum Adropin levels between the groups (p = 0.81). A correlation analysis revealed a negative association between the ENHO expression and age (r = −0.47, p = 0.009), whereas the serum Adropin levels were positively correlated with age, disease onset, and diagnostic delay (p < 0.05). No significant associations were found between the ENHO expression and Adropin levels or FMF clinical features. These findings suggest that increased ENHO expression may play a role in FMF pathophysiology, potentially as a compensatory mechanism. The correlation between Adropin levels and disease onset indicates a potential protective role. Further studies are needed to confirm these findings.

  • Open Access

    Investigation of HIF1A gene polymorphisms in patients with allergic rhinitis

    by Bünyamin Yaşar, Hüseyin Günizi, Durkadın Demir Ekşi

    Aim: Allergic rhinitis (AR) is a chronic inflammatory disease caused by IgE-mediated hypersensitivity to environmental allergens. In Türkiye, AR prevalence ranges between 11.8% and 36.4%. The Hypoxia Inducible Factor 1 Subunit Alpha (HIF1A) gene plays a significant role in hypoxia and inflammation-related pathways, and its polymorphisms have been associated with various inflammatory diseases. This study aimed to investigate the association of C1772T and C111A polymorphisms in the HIF1A gene with AR. Material and Methods: The study included 100 AR patients and 100 healthy controls. Single Nucleotide Polymorphism (SNP) analyses were performed using PCR-RFLP and validated by Sanger sequencing. Serum total IgE levels were measured, and patients were classified based on disease severity and duration. Genotype findings were compared with patients' clinical features. Results: The C111A SNP was non-polymorphic in both groups, as all individuals had the wild-type CC genotype. The C1772T SNP showed no significant differences in genotype or allele frequencies between patients and controls. Similarly, no significant associations were observed in patient subgroups stratified by disease severity, frequency, or serum IgE levels. Conclusion: This study demonstrated that these two polymorphisms in the HIF1A gene are not associated with AR development in the Turkish population. However, the literature indicates that HIF1A mRNA and protein levels affect AR. Results may vary due to genetic and environmental factors. Further studies investigating alternative polymorphisms in the HIF1A gene and its expression levels are needed to better understand the relationship between AR and HIF1A.

  • Open Access

    The Role of WNT3A Protein and Gene Variants in Allergic Rhinitis: A Case-Control Study

    by Durkadin Demir Eksi, Huseyin Gunizi

    Allergic rhinitis (AR) is a prevalent inflammatory disorder of the upper respiratory tract, driven by allergen exposure. Understanding mechanisms and identifying biomarkers for AR could significantly impact diagnosis and treatment. This study aimed to investigate the association between serum Wingless-Type MMTV Integration Site Family, Member 3A (WNT3A) protein levels, WNT3A polymorphisms, and AR. A cohort of 92 AR patients and 86 healthy controls was recruited. Serum WNT3A levels were measured by enzyme-linked immunosorbent assay (ELISA). WNT3A gene polymorphisms (rs752107 and rs3121310) were analyzed using Polymerase Chain Reaction- Restriction Fragment Length Polymorphism (PCR-RFLP) method. The study revealed significantly higher serum WNT3A levels in AR patients compared to controls (p < 0.0001). The impact of WNT3A in the differential diagnosis of AR was determined to be moderate, with an area under the curve (AUC) value of 0.67 (95% Confidence Interval: 0.59–0.75) based on the receiver operating characteristic (ROC) curve analysis. The rs3121310 polymorphism showed a significant association with the GA genotype more prevalent in controls (p < 0.05). However, no significant relationship was observed between rs3121310 genotypes and clinical parameters of the patients. These findings suggest a role for WNT3A in AR pathogenesis, given the elevated serum levels in patients. Larger cohort studies are needed to validate these findings and explore serum WNT3A levels as a biomarker for AR diagnosis and treatment monitoring.


  • Open Access

    FNDC5 Geni Polimorfizmleri, Serum İrisin Düzeyleri ve Alerjik Rinit Arasındaki İlişkinin Yokluğu

    by Durkadın DEMİR EKŞİ, Hüseyin Güni̇zi̇

    Amaç: Alerjik rinit (AR), alerjen maruziyetine bağlı olarak tip 1 immünoglobulin E-aracılı reaksiyonlarla oluşan bir enflamatuar burun mukozası hastalığıdır. İrisin, egzersize yanıt olarak iskelet kasları tarafından salınan bir hormondur. İrisin ile inflamasyon ilişkisini gösteren çalışmalar bulunmaktadır. Bu çalışmada, irisin kodlayan fibronektin tip III domain 5 (FNDC5) gen polimorfizmleri, serum irisin seviyeleri ve AR arasındaki potansiyel ilişkiyi araştırılmayı amaçladık. Yöntem: Çalışma, 100 AR hastası ve 100 sağlıklı kontrol bireyin yer aldığı bir vaka-kontrol tasarımı şeklinde dizayn edilmiştir. FNDC5 geninde bulunan rs726344 ve rs1746661 SNP'lerin genotipleme analizleri PCR-RFLP yöntemiyle gerçekleştirilmiştir. Serum irisin seviyeleri ELISA yöntemi ile ölçülmüştür. Sonuçlar: Hasta grubunda rs726344 SNP genotipleme sonuçlarına göre, %90 GG ve %10 GA genotipleri saptanırken, kontrol grubunda sırasıyla %94 GG ve %6 GA genotipleri belirlendi. AA genotipi hiçbir olguda saptanmadı. rs1746661 SNP için ise hastalarda %57 GG, %39 GT ve %4 TT genotipleri, kontrollerde ise sırasıyla %58 GG, %36 GT ve %6 TT genotipleri saptandı. Hastalar ile kontroller arasında rs726344 ve rs1746661 SNP'lerinde genotipik farklılık saptanmadı. Serum irisin seviyesi, hastalarda 406.3±56.09 ng/ml iken, kontrollerde 354.3±46.06 ng/ml olarak bulundu ve aralarında anlamlı farklılık görülmedi. Sonuç: Bu çalışma, irisin proteininin, kodlayıcı geni ve AR arasındaki ilişkiyi araştırmayı amaçlayan ilk çalışmadır. FNDC5 gen polimorfizmleri, serum irisin seviyeleri ve AR arasında anlamlı bir ilişki saptanmamıştır. Bu bulgular, bu faktörlerin AR gelişiminde sınırlı bir rolünü göstermekle birlikte, irisin-AR ilişkisinin anlaşılması için ileri çalışmalara ihtiyaç bulunmaktadır.


  • Open Access

    Effect of serum adropin levels on circulating endothelial dysfunction biomarkers in COVID-19 patients

    by Ramazan Güneşaçar, Durkadın DEMİR EKŞİ, Ali Seydi Alpay, Ferhat Hani̇kOğlu, Haluk Erdoğan

    Purpose: Several studies show that the symptoms of severe COVID-19 infection reflect the clinical phenotype of endothelial dysfunction and share common pathophysiological mechanisms with endothelial dysfunction. Therefore, the aim of the study was to investigate the effect of serum adropin levels on endothelial dysfunction biomarkers and determine whether adropin could be a new biomarker for COVID-19. Materials and Methods: The study included 40 patients with mild/moderate COVID-19, 48 patients with severe/critical COVID-19, and 37 controls. Serum adropin and circulating biomarkers of endothelial dysfunction including asymmetric dimethylarginine (ADMA), endothelin-1 (ET-1), endothelial nitric oxide synthase (eNOS), soluble intercellular adhesion molecule-1 (sICAM-1) and plasminogen activator inhibitor-1 (PAI-1) levels were determined by micro-ELISA. Results: Serum adropin levels were found to be significantly higher in COVID-19 patients (165.2±11.49 pg/ml) than in controls (85.46±12.08 pg/ml). Serum adropin levels of patients with severe/critical symptoms (194±16.23 pg/ml) were significantly higher than the patients with mild/moderate symptoms (130.6 ±14.53). In addition, serum ADMA, eNOS, and, ET-1 levels were significantly higher in the COVID-19 subjects (150.5±8.67 ng/ml, 172.4±14.01 pg/ml, 159.3±10.19 pg/ml, respectively) than that those in the controls (104.5±9.182 ng/ml, 141.4±17.74 pg/ml, 100.1±11.37 pg/ml, respectively). Significant positive correlations were found between adropin and ADMA, eNOS, ET-1, sICAM-1, and PAI-1 levels in the patients. Conclusion: We suggest that adropin may be a new potential biomarker for COVID-19 and an important molecule in restoring endothelial cell damage. Positive correlations between serum adropin levels and ADMA, eNOS, ET-1, sICAM-1 and PAI-1 levels in patients suggest that adropin may compensate for damage to endothelial cells.


  • Kromozomal Mikroarray ve Tıpta Kullanımı

    by Durkadın Demir Ekşi

    Kromozomal mikroarray (KMA) tekniği, bütün kromozomlar boyunca dağılmış moleküler belirteçleri kullanarak submikroskobik delesyon, duplikasyon ve dengesiz yeniden düzenlenmeleri belirleyen üstün bir moleküler karyotipleme metodudur. Geleneksel G bantlama yöntemi ancak 5-10 Mb büyüklüğündeki anomalileri saptayabilirken, KMA kilobaz aralığındaki kopya sayısı varyasyonlarını (CNV) başarıyla tespit eder. Günümüzde prenatal ve postnatal genetik tanıda yaygınlaşan bu teknoloji, özellikle aCGH ve SNP array olmak üzere iki temel yaklaşımla uygulanmaktadır. KMA; otizm spektrum bozukluğu, gelişme geriliği, entelektüel yetersizlik, çoklu konjenital anomaliler ve ultrasonografide yapısal anomali saptanan fetuslar için kılavuzlarda birinci basamak klinik test olarak önerilmektedir. Yapılan geniş kapsamlı prenatal çalışmalar, USG anomalisi olan fetuslarda KMA’nın patojenik bulguları saptama oranını %6-7 artırdığını göstermektedir. Postnatal dönemde ise geleneksel yöntemlerin %3-5 olan başarı oranına karşılık, KMA nörogelişimsel bozukluğu olan çocukların %15-20'sinde etiyolojiyi aydınlatabilmektedir. Hücre kültürüne ihtiyaç duymadan doğrudan DNA'dan hızlı sonuç veren bu yöntem, dengeli kromozomal translokasyonları ve nokta mutasyonlarını ise saptayamamaktadır. Chromosomal microarray (CMA) technique is an advanced molecular karyotyping method that detects submicroscopic deletions, duplications, and unbalanced rearrangements using molecular markers distributed across all chromosomes. While conventional G-banding can only capture anomalies of 5-10 Mb in size, CMA successfully identifies copy number variations (CNVs) in the kilobase range. Increasingly integrated into prenatal and postnatal genetic diagnosis, this technology is utilized through two main platforms: aCGH and SNP array. CMA is recommended as a first-tier clinical test in guidelines for children with autism spectrum disorder, developmental delay, intellectual disability, multiple congenital anomalies, and fetuses presenting with structural abnormalities on ultrasonography. Comprehensive prenatal studies demonstrate that CMA increases the detection rate of pathogenic findings by 6-7% in fetuses with ultrasound anomalies. Postnatally, whereas traditional methods yield a success rate of only 3-5%, CMA elucidates the etiology in 15-20% of children with neurodevelopmental disorders. This method provides rapid results directly from isolated DNA without requiring cell culture; however, it cannot detect balanced chromosomal translocations and point mutations.

  • COVID-19 ve Endotelyal Disfonksiyon: Moleküler Yaklaşım

    by Durkadın Demir Ekşi, Ramazan Güneşaçar

    COVID-19, SARS-CoV-2 virüsünün yol açtığı, dünya genelinde hızla yayılarak küresel halk sağlığını tehdit eden ve çoklu organ yetmezliğine neden olabilen multisistemik bir hastalıktır. Virüs, konakçı hücreye yüzeyindeki ACE2 reseptörüne bağlanarak giriş yapar; bu reseptörün farklı dokularda bulunması hastalığın multisistemik etkilerini ve bireyler arası seyir farklılıklarını açıklar. Klinik seyir hafif, orta, ciddi ve kritik olarak sınıflandırılmakta, ağır vakalarda hiperinflamasyonla karakterize sitokin salınımı sendromu (sitokin fırtınası) gelişmektedir. Son kanıtlar, şiddetli COVID-19 patofizyolojisinde endotel disfonksiyonunun ve sistemik endotelitin merkezi bir rol oynadığını; derin ven trombozu, pulmoner emboli ve mikrovasküler tromboz gibi jeneralize trombotik mikroanjiyopati tablolarının ortak paydası olduğunu göstermektedir. Ayrıca ileri yaş, hipertansiyon, diyabet ve obezite gibi kardiyovasküler risk faktörlerine sahip bireylerde endotel hasarı nedeniyle hastalığın daha şiddetli seyrettiği bildirilmiştir. Hastalığın takibinde ve kötü prognozun belirlenmesinde D-dimer, von Willebrand Faktör (vWF), PAI-1, Endotelin-1, sICAM-1, ADMA ve CRP gibi endotel disfonksiyonu biyobelirteçleri kritik öneme sahiptir. Vasküler homeostazı düzenleyen eNOS kaynaklı nitrik oksit (NO) düzeyindeki azalma ise oksidatif stresi artırarak endotel hasarını ve viral duyarlılığı şiddetlendirmektedir. COVID-19 is a multisystemic disease caused by the SARS-CoV-2 virus, which has rapidly spread worldwide, threatening global public health and potentially causing multi-organ failure. The virus enters the host cell by binding to the ACE2 receptor on the cell surface; the presence of this receptor in various tissues explains the multisystemic effects and the variance in clinical course among individuals. The clinical course is classified as mild, moderate, severe, and critical, with heavy cases developing cytokine release syndrome (cytokine storm) characterized by hyperinflammation. Recent evidence indicates that endothelial dysfunction and systemic endotheliitis play a central role in severe COVID-19 pathophysiology, serving as the common denominator for generalized thrombotic microangiopathy conditions such as deep vein thrombosis, pulmonary embolism, and microvascular thrombosis. Furthermore, it has been reported that the disease progresses more severely in individuals with cardiovascular risk factors like advanced age, hypertension, diabetes, and obesity due to endothelial injury. Endothelial dysfunction biomarkers, including D-dimer, von Willebrand Factor (vWF), PAI-1, Endothelin-1, sICAM-1, ADMA, and CRP, are of critical importance in tracking the disease and determining poor prognosis. Conversely, the decrease in eNOS-derived nitric oxide (NO) levels, which regulates vascular homeostasis, increases oxidative stress, thereby exacerbating endothelial damage and viral susceptibility.

  • Güncel Tıbbi Biyoloji ve Genetik Çalışmaları II

    by Meral Dağ, Muhittin Yürekli, Hülya Gündeşli, Özge Şükrüoğlu Erdoğan, Bakiye Göker Bağca, Çığır Biray Avcı, Umut Kerem Kolaç, Eren Kaan İpEk, Nazmiye Bitgen, Egemen Akgün, et al.

    Akademisyen Yayınevi yöneticileri, yaklaşık 30 yıllık yayın tecrübesini, kendi tüzel kişiliklerine aktararak uzun zamandan beri, ticarî faaliyetlerini sürdürmektedir. Anılan süre içinde, başta sağlık ve sosyal bilimler, kültürel ve sanatsal konular dahil 2000 kitabı yayımlamanın gururu içindedir. Uluslararası yayınevi olmanın alt yapısını tamamlayan Akademisyen, Türkçe ve yabancı dillerde yayın yapmanın yanında, küresel bir marka yaratmanın peşindedir.Bilimsel ve düşünsel çalışmaların kalıcı belgeleri sayılan kitaplar, bilgi kayıt ortamı olarak yüzlerce yılın tanıklarıdır. Matbaanın icadıyla varoluşunu sağlam temellere oturtan kitabın geleceği, her ne kadar yeni buluşların yörüngesine taşınmış olsa da, daha uzun süre hayatımızda yer edineceği muhakkaktır.

  • Novel Gene Variants Associated with Primary Ciliary Dyskinesia

    by Durkadin Demir Eksi, Elanur Yilmaz, A. Erdem Basaran, Gizem Erduran, Banu Nur, Ercan Mihci, Bulent Karadag, Aysen Bingol, Ozgul M. Alper

    Objectives To determine the demographic, clinical, and genetic profile of Turkish Caucasian PCD cases. Methods Targeted next-generation sequencing (t-NGS) of 46 nuclear genes was performed in 21 unrelated PCD cases. Sanger sequencing confirmed of potentially disease-related variations, and genotype–phenotype correlations were evaluated. Results Disease-related variations were identified in eight different genes (CCDC39, CCDC40, CCDC151, DNAAF2, DNAAF4, DNAH11, HYDIN, RSPH4A) in 52.4% (11/21) of the cases. The frequency of variations for CCDC151, DNAH11, and DNAAF2 genes which were highly mutated genes in the cohort was 18% in 11 patients. Each of the remaining gene variations was detected once (9%) in different patients. The variants, p.R482fs*12 in CCDC151, p.E216* in DNAAF2, p.I317* in DNAAF4, p.L318P and p.R1865* in DNAH11, and p.N1505D and p.L1167P in HYDIN gene were identified as novel variations. Interestingly, varying phenotypic findings were identified even in patients with the same mutation, which once again confirmed that PCD has a high phenotypic heterogeneity and shows individual differences. Conclusion This t-NGS panel is potentially helpful for exact and rapid identification of reported/novel PCD-disease–causing variants to establish the molecular diagnosis of ciliary diseases.